Tyra Biosciences, Inc. SEC filings TYRA
Tyra Biosciences, Inc. has 426 filings in SEC EDGAR's recent list, going back to May 28, 2021. Its latest annual report, Form ARS, was filed on Apr 17, 2026 for the period ended Dec 31, 2025. The latest quarterly report (Form 10-Q) was filed on Aug 4, 2026, covering the quarter ended Jun 30, 2026. The most recent current report (Form 8-K) was filed on Sep 15, 2026 (other events). The company's fiscal year ends on December 31.
| Form | Description | Filed | Period |
|---|---|---|---|
| 8-K |
Current report
Other events
|
Sep 15, 2026 | Sep 14, 2026 |
| 8-K |
Current report
Other events
|
Sep 9, 2026 | Sep 9, 2026 |
| 8-K |
Current report
Results of operations
|
Aug 4, 2026 | Aug 4, 2026 |
| 8-K |
Current report
Shareholder vote results
|
Jun 2, 2026 | May 28, 2026 |
| 8-K |
Current report
Results of operations
|
May 13, 2026 | May 13, 2026 |
| 8-K |
Current report
Officer or director change
|
Apr 17, 2026 | Apr 16, 2026 |
| 8-K |
Current report
Officer or director change
|
Apr 2, 2026 | Apr 1, 2026 |
| 8-K |
Current report
Other events
|
Mar 4, 2026 | Mar 4, 2026 |
| 8-K |
Current report
Results of operations
|
Mar 2, 2026 | Mar 2, 2026 |
| 8-K |
Current report
Officer or director change
|
Dec 1, 2025 | Nov 25, 2025 |
| 8-K |
Current report
Results of operations
|
Nov 5, 2025 | Nov 5, 2025 |
| 8-K |
Current report
Other events
|
Aug 22, 2025 | Aug 21, 2025 |
| 8-K |
Current report
Results of operations
|
Aug 14, 2025 | Aug 14, 2025 |
| 8-K |
Current report
Other events
|
Jun 30, 2025 | Jun 30, 2025 |
| 8-K |
Current report
Shareholder vote results
|
May 29, 2025 | May 29, 2025 |
| 8-K |
Current report
Results of operations
|
May 8, 2025 | May 8, 2025 |
| 8-K |
Current report
Results of operations
|
Mar 27, 2025 | Mar 27, 2025 |
| 8-K |
Current report
Officer or director change
|
Jan 29, 2025 | Jan 28, 2025 |
| 8-K |
Current report
Results of operations
|
Nov 7, 2024 | Nov 7, 2024 |
| 8-K |
Current report
Other events
|
Oct 28, 2024 | Oct 28, 2024 |
| 8-K |
Current report
Officer or director change, Regulation FD disclosure, Other events
|
Oct 25, 2024 | Oct 24, 2024 |
| 8-K |
Current report
Unregistered share sale
|
Oct 18, 2024 | Oct 18, 2024 |
| 8-K |
Current report
Results of operations
|
Aug 7, 2024 | Aug 7, 2024 |
| 8-K |
Current report
Change to shareholder rights, Bylaw or fiscal year change, Shareholder vote results
|
May 31, 2024 | May 29, 2024 |
| 8-K |
Current report
Results of operations
|
May 9, 2024 | May 9, 2024 |
| 8-K |
Current report
Officer or director change
|
May 7, 2024 | May 4, 2024 |
| 8-K |
Current report
Results of operations
|
Mar 19, 2024 | Mar 19, 2024 |
| 8-K |
Current report
Material agreement, Unregistered share sale, Regulation FD disclosure
|
Feb 5, 2024 | Feb 1, 2024 |
| 8-K |
Current report
Other events
|
Feb 1, 2024 | Feb 1, 2024 |
| 8-K |
Current report
Other events
|
Dec 22, 2023 | Dec 22, 2023 |
| 8-K |
Current report
Results of operations
|
Nov 7, 2023 | Nov 7, 2023 |
| 8-K |
Current report
Bylaw or fiscal year change
|
Oct 26, 2023 | Oct 26, 2023 |
| 8-K |
Current report
Results of operations
|
Aug 10, 2023 | Aug 10, 2023 |
| 8-K |
Current report
Shareholder vote results
|
Jun 2, 2023 | May 31, 2023 |
| 8-K |
Current report
Results of operations
|
May 4, 2023 | May 4, 2023 |
| 8-K |
Current report
Results of operations
|
Mar 22, 2023 | Mar 22, 2023 |
| 8-K |
Current report
Officer or director change, Other events
|
Mar 1, 2023 | Feb 27, 2023 |
| 8-K |
Current report
Other events
|
Nov 29, 2022 | Nov 29, 2022 |
| 8-K |
Current report
Results of operations, Officer or director change
|
Nov 3, 2022 | Oct 28, 2022 |
| 8-K |
Current report
Material agreement
|
Oct 3, 2022 | Oct 3, 2022 |
| 8-K |
Current report
Results of operations
|
Aug 4, 2022 | Aug 4, 2022 |
| 8-K |
Current report
Shareholder vote results
|
Jun 14, 2022 | Jun 13, 2022 |
| 8-K |
Current report
Results of operations
|
May 5, 2022 | May 5, 2022 |
| 8-K |
Current report
Results of operations
|
Mar 3, 2022 | Mar 3, 2022 |
| 8-K |
Current report
Results of operations, Regulation FD disclosure
|
Nov 3, 2021 | Nov 3, 2021 |
| 8-K |
Current report
Bylaw or fiscal year change, Other events
|
Sep 17, 2021 | Sep 17, 2021 |
Showing 46 filings. Main filings leave out insider and ownership forms such as Form 4; choose a type above to see them. Each form opens on SEC.gov. Older filings are on SEC EDGAR.
New to this? Read What Are SEC Filings? 10-K, 10-Q, 8-K and Other Forms Explained.
Company profile
- Industry
- Pharmaceutical Preparations (SIC 2834)
- Listed as
- TYRA (Nasdaq)
- Fiscal year ends
- December 31
- Incorporated in
- DE
- Headquarters
- Carlsbad, CA
- SEC filer status
- , Emerging growth company
- SEC CIK
- 1863127
Other Pharmaceutical Preparations companies
- ELI LILLY & Co LLY
- Johnson & Johnson JNJ
- AbbVie Inc. ABBV
- Merck & Co., Inc. MRK
- Novartis AG NVS
- Astrazeneca PLC AZN
- Abbott Laboratories ABT
- Novo Nordisk A S NVO
Source: SEC EDGAR filings. This is company-reported data, not investment advice.